Cardiovascular disease and risk factors in adults with hypopituitarism

Clinical Endocrinology

Volumn 50, Issue 1, 1999, Pages 1-15

  Beshyah, Salem A ^b   Johnston, Desmond G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE HOMEOSTASIS; GROWTH HORMONE DEFICIENCY; HEART DISEASE; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOPITUITARISM; LIFE EXPECTANCY; LIPID METABOLISM; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ADULT; BODY COMPOSITION; CARDIOVASCULAR DISEASES; FEMALE; GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LIFE EXPECTANCY; MALE; MORBIDITY; PREVALENCE; RISK FACTORS;

EID: 0002071662     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00682.x     Document Type: Review

References (146)

1. Al-Shoumer, K.A.S., Beshyah, S.A., Niththynanathan, R. & Johnston, D.G. (1995) The effects of glucocorticoid replacement regimen on glucose tolerance and intermediary metabolism in hypopituitary adults. Clinical Endocrinology, 42, 85-90.
2. Al-Shoumer, K.A.S., Ali, K., Anyaoku, V., Niththynanathan, R. & Johnston, D.G. (1996) Metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical Endocrinology, 45, 171-178.
3. Al-Shoumer, K.A.S., Cox, K.H., Hughes, C.L., Richmond, W. & Johnston, D.G. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. Journal of Clinical Endocrinology and Metabolism, 82, 2653-2659.
4. Amato, G., Carella, C., Fazio, S., Lamontagno, G., Cittadini, A., Sabatini, D., Marciano-Mone, C., Sacca, L. & Bellastella, A. (1993) Body composition, bone metabolism and heart structure and function in growth hormone (GH) deficient adults before and after GH replacement therapy. Journal of Clinical Endocrinology and Metabolism, 77, 1671-1676.
5. Barmnert, M., Berntorp, E., Groop, L. & Manhem, P. (1994). Effects of growth hormone replacement therapy on blood pressure regulation and coagulation factors. Endocrinology and Metabolism, 1 (Suppl. A), 57.
6. Bastenie, P.A., Vanhaelst, L., Bonnyns, M., Neve, P. & Staquet, E. (1971) Pre-clinical hypothyroidism: a risk factor for coronary heart disease. Lancet, 203-204.
7. Bates, A.S., Bullivant, B., Clayton, R.N., Sheppard, M.C. & Stewart, P.M. (1997) Increased mortality in hypopituitarism is not due to an increase in vascular mortality. Journal of Endocrinology, 152 (Suppl.), OC9.
8. Bates, A.S., Van't Hoff, W., Jones, P.J. & Clayton, R.N. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 1169-1172.
9. Bengtsson, B.-A., Eden, S., Lonn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tolli, J., Sjostrom, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology Metabolism, 76, 309-317.
10. Beshyah, S.A. (1994) Clinical and metabolic studies on hypopituitarism and growth hormone replacement therapy in adults. PhD Thesis, Imperial College, University of London, London.
11. Beshyah, S.A., Markussis, V., Harbourne, T., Nicolaides, A.N. & Johnston, D.G. (1993) Haemostatic mechanisms are normal despite increased vascular mortality in hypopituitary adults. Hormone and Metabolic Research, 25, 449-450.
12. Beshyah, S.A., Henderson, A., Niththyananthan, R., Sharp, P., Richmond, W. & Johnston, D.G. (1994a) Metabolic abnormalities in growth hormone deficient adults. II. Carbohydrate tolerance and lipid metabolism. Endocrinology and Metabolism, 1, 173-180.
13. Beshyah, S.A., Freemantle, C., Thomas, E., Rutherford, O.M., Page, B. & Johnston, D.G. (1995a) Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clinical Endocrinology, 42, 178-189.
14. Beshyah, S.A., Shahi, M., Skinner, E., Sharp, P., Foale, R. & Johnston, D.G. (1994b) Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. European Journal of Endocrinology, 130, 451-458.
15. Beshyah, S.A., Rutherford, O.M., Thomas, E., Murphy, M. & Johnston, D.G. (1995b). Assessment of regional body composition by dual energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. Endocrinology and Metabolism, 2, 147-155.
16. Beshyah, S.A., Gelding, S.V., Andres, C., Johnston, D.G. & Gray, I.P. (1995c). β-cell in hypopituitary adults before and after function growth hormone treatment. Clinical Science, 89, 321-328.
17. Beshyah, S.A., Freemantle, C., Shahi, M., Anyaoku, V., Merson, S., Lynch, S., Skinner, E., Sharp, P., Foale, R. & Johnston, D.G. (1995d). Replacement treatment with biosynthetic human growth in growth hormone-deficient hypopituitary adults. Clinical Endocrinology. 42, 73-84.
18. Beshyah, S.A., Henderson, A., Niththyananthan, R., Skinner, E., Anyaoku, V., Richmond, W., Sharp, P. & Johnston, D.G. (1995e). The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism, 80, 356-363.
19. Beshyah, S.A., Shahi, M., Mayet, J., Foale, R. & Johnston, D.G. (1996) Growth hormone and the cardiovascular system. In: The Complexity of Endocrine Systems (eds. M. Ranke & J.S. Christiansen), pp. 131-155. J and J-Verlag, Mannaheim.
20. Besser, G.M. & Jeffcoate, W.J. (1976) Adrenal diseases. British Medical Journal, 1, 448-451.
21. Beznak, M. (1954) The restoration of cardiac hypertrophy and blood pressure in hypophysectomized rats by large doses of lyophilized anterior pituitary and growth hormone. Journal of Physiology, 124, 64-74.
22. Binnerts, A., Deurenberg, P., Swart, G.R., Wilson, J.H.P. & Lamberts, S.W.J. (1992). Body composition in growth hormone deficient adults. American Journal of Clinical Nutrition, 55, 918-923.
23. Blackett, P.R., Weech, P.K., McConathy, W.J. & Fesmire, J.D. (1982) Growth hormone in the regulation of hyperlipidemia. Metabolism, 31, 117-120.
24. Bojs, G., Falkheden, T., Sjogren, B. & Varnauskas, E. (1965) Haemodynamic studies in man before and after hypophysectomy. Acta Endocrinologica, 39, 308-322.
25. Bougneres, P.-F., Artavia-Loria, E., Ferre, P., Chaussain, I.-L. & Job, J.-C. (1985) Effects of hypopituitarism and growth hormone replacement therapy on the production and utilisation of glucose in childhood. Journal of Clinical Endocrinology and Metabolism, 61, 1152-1167.
26. Brasel, J.A., Wright, J.C., Wilkins, L. & Blizzard, R.M. (1965) An evaluation of seventy-five patients with hypopituitarism begining in childhood. American Journal of Medicine, 38, 484-498.
27. Buchanan, C.R., Preece, M.A. & Milner, R.D.G. (1991) Mortality, neoplasia and Creutzfeldt- Jacob disease in patients treated human pituitary growth hormone in the United Kingdom. British Medical Journal, 302, 824-828.
28. Bulow, B., Hagmar, L., Mikoczy, Z., Nordstrom, C.H. & Erfurth, E.M. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology, 46, 75-81.
29. Burke, C.W. (1992) Primary adrenocortical failure. In: Clinical Endocrinology (ed. A. Grossman), pp. 393-404. Blackwell Scientific Publications, Oxford.
30. Caidhal, K., Eden, S. & Bengtsson, B.-A. (1994) Cardiovascular and renal effects of growth hormone. Clinical Endocrinology, 40, 393-400.
31. Capaldo, B., Patti, L., Oliviero, U., Longobardi, S., Pardo, F., Vitale, F., Fazio, S., Di Rella, F., Biondi, B., Lombardi, G. & Saccà, L. (1997) Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 1378-1381.
32. Cittadini, A., Cuocolo, A., Merola, B., Fazio, S., Sabatini, D., Nicolai, E., Colao, A., Longobardi, S., Lombardi, G. & Sacca, L. (1994) Impaired cardiac performance in GH-deficient adults and its improvement after GH Replacement. American Journal of Physiology, 267, E219-E225.
33. Clarkson, P., Wheeldon, N.M. & MacDonald, T. (1994) Left ventricular diastolic function. Quarterly Journal of Medicine, 87, 143-148.
34. Cryer, P.E. (1992) Glucose homeostatsis and hypoglycaemia. In: William's Textbook of Endocrinology, (eds. J.D. Wilson, & D.W. Foster) pp. 1223-1245. Saunders, Philadilphia.
35. Cuneo, R.C., Salomon, F., Wilmhurst, P., Byrne, C., Wiles, C.M., Hesp, R. & Sonksen, P.H. (1991a). Cardiovascular effects of growth hormone treatment in growth hormone-deficient adults: stimulation of the renin-aldesterone system. Clinical Science, 81, 587-592.
36. Cuneo, R.C., Salomon, F., Wiles, C.M., Hesp, R. & Sonksen, P.H. (1991b) Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance. Journal of Applied Physiology. 70, 695-700.
37. Cuneo, R.C., Salomon, F., MacGauley, G.A, & Sonksen, P.H. (1992) The growth hormone deficiency syndrome in adults. Clinical Endocrinology, 37, 387-397.
38. Cuneo, R.C., Salomon, F., Watts, G.F., Hesp, R. & Sönksen, P.H. (1993) Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism, 42, 1519-1523.
39. Cuneo, R.C., Judd, S., Wallace, J.D., Perry-Keene, D., Burger, H., Lim-Tio, S., Strauss, B., Stockigt, J., Topliss, D., Alford, F., Hew, L., Bode, H., Conway, A., Handelsman, D., Dunn, S., Boyages, S., Cheung, N.W. & Hurley, D. (1998). The australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 83, 107-116.
40. Davidson, M.B. (1987) Effect of growth hormone on carbohydrate and lipid metabolism. Endocrine Reviews, 8, 115-131.
41. De-Gennes, J.L., Turpin, G., Heshmati, H.M. & Lebrun, A. (1979) Hypopituitarisme et hyperlipidemie. Effet preventif du deficit somatotrope sur le developpement de l'atherosclerose. Apropos de 12 observations. Annals Endocrinologic Paris, 40, 557-558.
42. DeBoer, H., Blok, G.J., Voerman, H.J., De Vries, P.M.J.M. & Van Der Veen, E.A. (1992) Body composition in adult growth hormone deficient men, assessed by anthropometry and bioimpedance analysis. Journal of Clinical Endocrinology and Metabolism, 75, 833-837.
43. DeBoer, H., Blok, G.J., Voerman, H.J., Philips, M. & Schouten, J.A. (1994) Serum lipids in growth hormone deficient men. Metabolism, 43, 199-203.
44. DeVile, C.J. & Stanhope, R. (1997) Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clinical Endocrinology, 47, 37-41.
45. Drury, P.L. & Besser, G.M. (1989) Adrenal cortex. In: Fundamentals of Clinical Endocrinology (eds. R. Hall & G.M. Besser), pp. 153-184. Churchill Livingstone, London.
46. Dunne, F.P., Elliot, P., Gammage, M.D., Stalland, T., Ryan, T., Sheppard, M.C. & Stewart, P.M. (1995) Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clinical Endocrinology, 43, 623-629.
47. Eden, S., Wilklund, O., Oscarsson, J., Rosen, T. & Bengtsson, B.-A. (1993) Growth hormone treatment of growth hormone-deficient adults results in marked increase in Lp (a) and HDL cholesterol concentrations. Arteriosclerosis and Thrombosis, 13, 296-301.
48. Erfurth, E.M. & Hagmar, L. (1998) Cardiovascular mortality among pituitary insufficient patients. Clinical Endocrinology, 49, 271-272.
49. Feek, C.M., Ratcliffe, J.G., Seth, J., Gray, C.E., Toft, A.D. & Irvine, W.J. (1981) Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clinical Endocrinology, 14, 451-458.
50. Florkowski, C.M., Collier, G.R., Zimmet, P.Z., Livesey, J.H., Espiner, E.A. & Donald, R.A. (1996) Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clinical Endocrinology, 45, 769-773.
51. Fort, S., Weaver, J.U., Monson, J.P. & Mills, P.G. (1995) The effect of low-dose recombinant human growth hormone on cardiovascular structure and function in growth hormone-deficient hypopituitary adults. Endocrinology and Metabolism, 2, 119-126.
52. Foss, M.C., Paula, F.J.A., Paccola, G.M.G.F. & Piccinato, C.E. (1995) Peripheral glucose metabolism in human hyperprolactinaemia. Clinical Endocrinology, 43, 721-726.
53. Fowelin, J., Attvall, S., Lager, I. & Bengtsson, B.A. (1993) Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism, 42, 1443-1447.
54. Garrow, J. (1991) Importance of obesity. British Medical Journal, 303, 704-706.
55. Gelding, S.V., Taylor, N.F., Wood, P.J., Noonan, K., Weaver, J.U., Wood, D.F. & Monson, J.P. (1998) The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 β-hydroxysteroid dehydrogenase activity. Clinical Endocrinolgy, 48, 153-162.
56. Geroulakos, G., O'Gorman, D., Nicolaides, A., Sheridan, D., Elkeles, R.S. & Sharper, A.G. (1994) Carotid intima-media thickness: correlation with the British Regional Heart Study risk score. Journal ofternal Medicine, 235, 431-433.
57. Greenman, Y., Tordjman, K. & Stern, N. (1998) Increased body weight associated with prolactin secreting adenomas: weight loss with normalization of prolactin levels. Clinical Endocrinology, 48, 547-553.
58. Haarbo, J., Marslew, U., Gotfredsen, A. & Christiansen, C. (1991) Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism, 40, 1323-1326.
59. Haffner, S.M, Stern, M.P., Hazuda, H.P., Rosenthal, M., Knapp, J.A. & Melina, R.M. (1986) Role of obesity and fat distribution in non-insulin dependent diabetes mellitus in Mexican Americans and non-Hispanic whites. Diabetes Care, 9, 153-161.
60. Hall, R. (1972) Diagnosis and management of hypopituitarism. Journal of the Royal College of Physicians of London, 7, 19-33.
61. Hayward, R.P., Emanuel, R.W. & Nabarro, J.D.N. (1987) Acromegalic heart disease: influence of the treatment of the acromegaly on the heart. Quarterly Journal of Medicine, 62, 41-58.
62. Hew, F.L., Koschmann, M., Kreiger, K., Christopher, M., Rantzau, C., Ward, G., Best, J.D. & Alford, F.P. (1995) Insulin Tolerance sensitivity in patients with anterior pituitary hormone deficiency: reduced insulin sensitivity. Endocrinology and Metabolism, 2, 93-98.
63. Hirsch, E.Z., Sloman, J.G. & Martin, F.I. (1969) Cardiac function in acromegaly. American Journal of Medical Science, 257, 1-8.
64. Hjalmarson, A., Isaksson, O. & Ahren, K. (1969) Effects of growth hormone and insulin on amino acid transport in perfused rat heart. American Journal of Physiology, 217, 1795-1802.
65. Ho, K.Y. & Weissberger, A.J. (1990) The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism, 39, 133-137.
66. Hopwood, N.J., Forsman, P.J., Kenney, F.M. & Drash, A.L. (1975) Hypoglycaemia in hypopituitary children. American Journal of Diseases of Children, 129, 918-929.
67. Howlett, T.A., Rees, L.H. & Besser, G.M. (1985) Cushing's syndrome. Clinics in Endocrinology and Metabolism, 14, 911-945.
68. Howlett, T.A. (1997) An assessment of optimal hydrocortisone replacement therapy. Clinical Endocrinology, 46, 263-268.
69. Hwu, C.-M., Kwok, C.F., Lai, T.-Y., Shih, K.-C., Lee, T.S., Hsiao, L.-C., Lee, S.H., Fang, V.S. & Ho, L.T. (1997) Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. Journal of Clinical Endocrinology and Metabolism, 82, 3285-3292.
70. Ishibashi, S., Murase, T., Yamada, N., Tanaka, K., Takaku, F. & Sato, K. (1985) Hyperlipidaemia in patients with hypopituitarism. Acta Endocrinologica, 110, 456-460.
71. Johannsson, G., Bengtsson, B.-A., Andersson, B., Isgaard, J. & Caidahl, K. (1996) Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clinical Endocrinology, 45, 305-314.
72. Johannsson, G., Merin, P., Lynn, L., Ottosson, M., Stenlöf, K., Bjorntorp, P., Sjostrom, L. & Bengtsson, B.A. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism, 82, 727-734.
73. Johansson, J.-O., Landin, K., Tengborn, L., Rosen, T. & Bengtsson, B.-A. (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arteriosclerosis and Thrombosis, 14, 434-437.
74. Johansson, J.-O., Landin, K., Johannsson, G., Tengborn, L. & Bengtsson, B.-A. (1996) Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thrombosis and Haemostasis, 76, 422-428.
75. Johnston, D.G., Alberti, K.G.M.M., Nattrass, M., Barnes, A.J., Bloom, S.R. & Joplin, G.F. (1980) Hormonal and metabolic rhythms in Cushing's syndrome. Metabolism, 29, 1046-1052.
76. Jorgensen, J.O.L., Pederson, S.A., Ingerslev, J., Moller, J., Skakkebaek, N.E. & Christiansen, J.S. (1990) Growth hormone (GH) therapy in GH-deficient patients, the plasma factor VIII-von Willebrand factor complex and capillary fragility. A double-blind, placebo-controlled cross over study. Scandanavian Journal of Clinical and Laboratory Investigations, 50, 417-420.
77. Jorgensen, J.O.L., Pederson, S.A., Thuesen, L., Jorgensen, J., Ingemann-Hansen, T., Skakkehaek, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, i, 1221-1225.
78. Kehlet, H., Binder, C. & Blichert-Toft, M. (1976) Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clinical Endocrinology, 5, 37-41.
79. Kissebah, A.H., Vydelinghum, N., Murray, R., Evans, D.J., Hartz, A.J., Kalkhoff, R.K. & Adams, P.W. (1982) Relationship of body fat distribution to metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism, 54, 254-260.
80. Lam, K.S., Pang, R.W., Janus, E.D., Kung, A.W. & Wang, C.C. (1993) Serum apolipoprotein (a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis, 104, 183-188.
81. Landin-Wilhelmsen, K., Tengborn, L., Wilhelmsen, L. & Bengtsson, B.-A. (1997) Elevated fibrinogen levels decrease following treatment of acromegaly. Clinical Endocrinology, 46, 69-74.
82. Landon, J., Greenwood, F.C., Stamp, T.C.B. & Wynn, V. (1966) The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin and the comparison of this procedure with other tests of pituitary and adrenal function. II: Patients with hypothalamic or pituitary dysfunction or anorexia nervosa. Journal of Clinical Investigation, 45, 437-449.
83. Lapidus, L., Bengtson, C., Larsson, B., Pennert, K., Ryobo, E. & Sjostrom, L. (1984) Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. British Medical Journal, 289, 1257-1261.
84. Larsson, B., Svardsudd, K., Welin, L., Wilhelmsen, L., Bjorntorp, P. & Tibblin, G. (1984) Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. British Medical Journal, 288, 1401-1404.
85. Lehmann, E.D., Watts, G.F. & Gosling, R.G. (1992a) Aortic distensibility and hypercholesterolaemia. Lancet, 340, 1171-1172.
86. Lehmann, E.D., Gosling, R.G. & Sönksen, P.H. (1992b) Arterial wall compliance in diabetes. Diabetic Medicine, 9, 114-119.
87. Lehmann, E.D., Hopkins, K.D., Weissberger, A.J., Gosling, R.G. & Sönksen, P.H. (1993) Aortic distensibility in growth hormone deficient adults. Lancet, 341, 309.
88. Lehmann, E.D., Hopkins, K.D., Weissberger, A.J., Parker, J.R., Turay, R. & Gosling, R.G. (1994) Blood pressure corrected aortic distensibility in growth hormone deficient adults. Clinical Science, 83 (Suppl. 30), 64.
89. Ley, C.J., Lees, B. & Stevenson, J.C. (1992) Sex- and menopause-associated changes in body-fat distribution. American Journal of Clinical Nutrition, 55, 950-954.
90. Libber, S.M., Plotnick, L.P., Johanson, A.J., Blizzard, R.M., Kwiterovich, P.O. & Migeon, C.J. (1990) Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine, 69, 46-55.
91. Lip, G.Y.H., Beevers, G. & Zarifis, J. (1995) Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint. Journal of Internal Medicine, 238, 389-399.
92. Longobardi, S., Cuocolo, A., Merola, B., DeRella, F., Colao, A., Nicolai, E., Cardei, S., Salvatore, M. & Lombardi, G. (1998) Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clinical Endocrinology, 48, 137-144.
93. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicolaides, A.N. & Johnston, D.G. (1992). Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-1192.
94. Markussis, V., Beshyah, S.A., Fisher, C., Parker, K., Nicolaides, A.N. & Johnston, D.G. (1997) Abnormal carotid wall arterial wall dynamics in symptom-free hypopituitary adults. European Journal of Endocrinology, 136, 157-164.
95. Martins, J.B., Kerber, R.E., Sherman, B.M., Marcus, M.L. & Erhardt, J.C. (1977) Cardiac size and function in acromegaly. Circulation, 56, 863-869.
96. Mather, H.M., Bjod, M.J. & Jenkins, J.S. (1979) Heart size and function in acromegaly. British Heart Journal, 41, 697-701.
97. Matsumura, K., Abe, I., Fukuhara, M., Ohya, Y., Okamura, K. & Fujishima, M. (1994) Modulation of circadian rhythm of blood pressure by cortisol in patients with hypopituitarism. Clinical and Experimental Hypertension, 16, 55-66.
98. McHenry, P.L., O'Donnell, J., Moris, S.N. & Jordon, J.J. (1984) The abnormal exercise electrocardiogram in apparently healthy men: a predictor of angina pectoris as an initial coronary event during long term follow-up. Circulation, 70, 547-452.
99. Merimee, T.J., Felig, P., Marliss, E., Fineberg, S.E. & Cahill, G.C. (1971) Glucose and lipid homeostasis in the absence of human growth hormone. Journal of Clinical Investigation, 50, 574-582.
100. Merimee, T.J., Hollander, W. & Fineberg, S.E. (1972) Studies of hyperlipidaemia in the HGH-deficient state. Metabolism, 21, 1053-1061.
101. Merimee, T.J., Fineberg, S. & Hollander, W. (1973) Vascular disease in the chronic HGH-deficient state. Diabetes, 22, 813-819.
102. Merimee, T.J. (1978). A follow-up study of vascular disease in growth hormone-deficient dwarfs with diabetes. New England Journal of Medicine, 298, 1217-1222.
103. Merola, B., Cittadini, A., Colao, A., Longobardi, S., Fazio, S., Sabatini, D., Sacca, L. & Lombardi, G. (1993) Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 77, 1658-1661.
104. Modgiliani, E., Kercjouni, R., Uzzan, B., Valensi, P., Chanson, P. & Caron, J. (1994) Modification of blood lipids and lipoproteins after human growth hormone treatment in adults with growth hormone deficiency: a preliminary report. Endocrinology and Metabolism, 1 (Suppl. A), 31-35.
105. Monson, J.P. (1997) The assessment of glucocorticoid replacement therapy. Clinical Endocrinology, 46, 269-270.
106. Nass, R., Huber, R.M., Klauss, V., Muller, O.A., Schopohl, J. & Strasburger, C.J. (1995) Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. Journal of Clinical Endocrinology and Metabolism, 80, 552-557.
107. Nolte, W., Rodisch, C., Armstrongl, V.W., Hüfner, H. & von zur Mühlen, V. (1997) The effect of recombinant human GH replacement therapy on lipoprotein (a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial. European Journal of Endocrinology, 137, 459-466.
108. O'Halloran, D.J., Wieringa, G., Tsatsoulis, A. & Shalet, S.M. (1996) Increased serum lipoprotein (a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency. Annals of Clinical Biochemistry, 33, 330-334.
109. O'Neal, D.N., Kalfas, A., Dunning, P.L., Christopher, M.J., Swayer, S.D., Ward, G.M. & Alford, F.P. (1994) The effect of 3 months of recombinant growth hormone (GH) therapy on insulin and Glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. Journal of Clinical Endocrinology and Metabolism, 79, 975-983.
110. Olivecrona, H., Ericsson, S., Berglund, L. & Angelin, B. (1993) Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment. British Medical Journal, 306, 1726-1727.
111. Olivecrona, H., Johansson, A.G., Lindh, E., Ljunghall, S., Berglund, L. & Angelin, B. (1995) Hormonal regulation of serum lipoprotein (a) levels: contrasting effects of growth hormone and insulin like growth factor-I. Arteriosclerosis, Thrombosis and Vascular Biology, 15, 847-849.
112. Padayatty, S.J., Orme, S., Zenobi, P.D., Stickl, M.H., Belchetz, P.E. & Grant, P.J. (1993) The effects ofsulin-like growth factor-I on plasminogen activator inhibitor-1 synthesis and secretion: results from in vitro and in vivo studies. Thrombosis and Haemostasis, 70, 1009-1013.
113. Page, R.C., Levy, J. & Turner, R.C. (1994) Obesity associated insulin resistance occurs in hypopituitary subjects. Diabetic Medicine, 11, 862-865.
114. Peacey, S.R., Guo, C.-Y., Robinson, A.M., Price, A., Giles, R., Eastell, R. & Weetman, A.P. (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology, 46, 255-262.
115. Plotz, M., Kowlton, A.I. & Ragan, C. (1952). Natural history of Cushing's syndrome. American Journal of Medicine, 13, 597-614.
116. Press, M. (1988) Growth hormone and metabolism. Diabetes and Metabolism Reviews, 4, 391-414.
117. Pupo, A.A., Wajchenberg, B.L. & Schnaider, J. (1966) Carbohydrate metabolism in hyperadrenocortisolism. Diabetes, 15, 24-29.
118. Rodriguez-Arnao, J., Perry, L., Besser, G.M. & Ross, R.J.M. (1996) Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clinical Endocrinology, 45, 33-37.
119. Rosen, T. & Bengtsson, B.-A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
120. Rosen, T., Eden, S., Larson, G., Wilhemsen, L. & Bengtsson, B.-A. (1993a) Cardiovascular risk factors in growth hormone deficient adults. Acta Endocrinologica, 129, 195-200.
121. Rosen, T., Bosaeus, I., Tolli, J., Lindstedt, G. & Bengtsson, B.-A. (1993b) Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clinical Endocrinology, 38, 63-71.
122. Rosen, T., Johannsson, G., Hallgren, P., Caidhal, C., Bosaeus, I. & Bengtsson, B.-A. (1994) Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinology and Metabolism, 1, 55-66.
123. Rosen, T., Wilhelmsen, L. & Bengtsson, B.-A. (1998) Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency. Clinical Endocrinology, 48, 525-526.
124. Russell-Jones, D.L., Watts, G.F., Weissherger, A., Naoumova, R., Myers, J., Thompson, G.R. & Sonksen, P.H. (1994). The effect of growth hormone on serum lipids, lipoproteins, apoproteins and cholesterol precursors in adult growth hormone deficient patients. Clinical Endocrinology, 41, 345-350.
125. Sagel, J., Lopes-Virella, M.F., Levin, J.H. & Colwell, J.A. (1979) Decreased high density lipoprotein cholesterol in hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 49, 753-756.
126. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
127. Salomon, F., Cuneo, R.C., Umpleby, A.M., & Sönksen, P.H. (1994) Interactions of body fat and muscle mass with substrate concentrations and fusting insulin levels in adults with growth hormone deficiency. Clinical Science, 87, 201-206.
128. Salonen, J.T. & Salonen, R. (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation, 87 (Suppl. 11), 1156-1165.
129. Scott, R.S., Donald, R.A. & Espiner, E.A. (1978) Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substituition therapy. Clinical Endocrinology, 9, 571-576.
130. Shahi, M., Beshyah, S.A., Hackett, D., Sharp, P.S., Johnston, D.G. & Foale, R.A. (1992) Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. British Heart Journal, 67, 92-96.
131. Snel, Y.E., Brummer, R.J., Doerga, M.E., Zelissen, P.M., Bakker, C.J., Hendriks, M.J. & Koppeschaar, H.P. (1995) Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. American Journal of Clinical Nutrition, 61, 1290-1294.
132. Stiegler, C. & Leb, G. (1994) One year of replacement therapy in adults with growth hormone deficiency. Endocrinology and Metabolism, 1 (Suppl. A), 37-42.
133. Taback, S.P., Dean, H.J. & Members of the Canadian Growth Hormone Advisory Committee (1996). Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-92. Journal of Clinical Endocrinology and Metabolism, 81, 1693-1696.
134. Taylor, R. (1991) Insulin action 1991. Clinical Endocrinology, 34, 159-171.
135. Thuesen, L., Jorgensen, J.O.L., Müller, J.R., Kristensen, B.O., Skakkebaek, N.E., Nina, V. & Christiansen, J.S. (1994). Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clinical Endocrinology, 41, 615-620.
136. Toogood, A.A., Adams, J.E., O'Neill, P.A. & Shalet, S. (1996) Body composition in growth hormone -deficient adults over the age of 60 years. Clinical Endocrinology, 45, 399-405.
137. Vague, J. (1956) The degree of musculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculus disease. American Journal of Clinical Nutrition, 4, 20-34.
138. Valcavi, R., Gaddi, O., Zini, M., Iavicoli, M., Mellino, U. & Portioli, I. (1995) Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment. Journal of Clinical Endocrinology and Metabolism, 80, 659-666.
139. Walker, B.R., Andrew, R., MacLeod, K.M. & Padfield, P.L. (1998) Growth hormone replacement inhibits renal and hepatic β-hydroxysteroid dehydrogenase in ACTH-deficient patients. Clinical Endocrinology, 49, 257-263.
140. Weaver, J.U., Thaventhiran, L., Noonan, K., Bunin, J.M., Taylor, N.F., Norman, M.R. & Monson, J.P. (1994) The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology, 41, 639-648.
141. Weaver, J.U., Monson, J.P., Noonan, K., John, W.G., Edwards, A., Evans, K. & Cunningham, J. (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 80, 153-159.
142. White, R.M., Schaefer, E.J. & Papadopoulos, N.M. (1983) The effect of growth hormone administration on lipids and lipoproteins in growth hormone-deficient patients. Proceedings of the Society of Experimental Biology and Medicine, 173, 63-67.
143. Whitehead, H.M., Boreham, C., McIlrath, E.M., Sheridan, B., Kennedy, L., Atkinson, A.B. & Hadden, D.R. (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross over study. Clinical Endocrinology, 36, 45-52.
144. Winter, R.J., Thompson, R.G. & Green, O.C. (1979) Serum cholesterol and triglycerides in children with growth hormone deficiency. Metabolism, 28, 1244-1249.
145. World Health Organisation (1985) Diabetes Mellitus. Report of a study group. Technical Report Series 727. WHO, Geneva.
146. Wüster, C., Slenczka, E. & Ziegler, R. (1991) Erholte pravalenz von osteoporose und arteriosklerose bei konventionell substituierter hypophysen vorderlappeninsuffizienz: bedarf einer zustzlichen wachstumshormonsubstitution? Klinische Wochenschrift, 69, 769-773.